U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Substance Class Protein
Created
by admin
on Sat Jun 26 18:00:48 UTC 2021
Edited
by admin
on Sat Jun 26 18:00:48 UTC 2021
Protein Type MONOCLONAL ANTIBODY
Protein Sub Type IGG1
Sequence Origin HUMANIZED MOUSE
Sequence Type COMPLETE
Record UNII
O43472U9X8
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
OBINUTUZUMAB
DASH   INN   MART.   USAN   VANDF   WHO-DD  
INN   USAN  
Official Name English
OBINUTUZUMAB [MI]
Common Name English
AFUTUZUMAB
Common Name English
RO5072759
Common Name English
RO 5072759
Code English
OBINUTUZUMAB [MART.]
Common Name English
HUMABCD20
Common Name English
OBINUTUZUMAB [USAN]
Common Name English
RG-7159
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
Common Name English
RO-5072759 HUMAB<CD20>
Code English
OBINUTUZUMAB [JAN]
Common Name English
OBINUTUZUMAB [VANDF]
Common Name English
GAZYVA
Brand Name English
OBINUTUZUMAB [PURPLE BOOK, CDER]
Common Name English
GA101
Code English
OBINUTUZUMAB [INN]
Common Name English
RO-5072759
Code English
IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL GA101 HEAVY CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL GA101 .KAPPA.-CHAIN, DIMER
Common Name English
HUMAB<CD20>
Code English
GAZYVARO
Brand Name English
OBINUTUZUMAB [WHO-DD]
Common Name English
GA-101
Code English
Classification Tree Code System Code
FDA ORPHAN DRUG 473315
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
WHO-ATC L01XC15
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
EU-Orphan Drug EU/3/14/1325
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
FDA ORPHAN DRUG 727719
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
FDA ORPHAN DRUG 592717
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
NCI_THESAURUS C129822
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
NCI_THESAURUS C141215
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
NDF-RT N0000175657
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
FDA ORPHAN DRUG 473415
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
EMA ASSESSMENT REPORTS GAZYVARO (AUTHORIZED: LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL)
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
FDA ORPHAN DRUG 360011
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
FDA ORPHAN DRUG 359911
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
WHO-VATC QL01XC15
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
Code System Code Type Description
RXCUI
974779
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY RxNorm
MERCK INDEX
M11722
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
DRUG BANK
DB08935
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
HSDB
8249
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
IUPHAR
6941
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
NCI_THESAURUS
C70741
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
DRUG CENTRAL
4983
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
FDA UNII
O43472U9X8
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
WIKIPEDIA
OBINUTUZUMAB
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
LACTMED
Obinutuzumab
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
INN
9043
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
EVMPD
SUB32751
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
ChEMBL
CHEMBL1743048
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
CAS
949142-50-1
Created by admin on Sat Jun 26 18:00:49 UTC 2021 , Edited by admin on Sat Jun 26 18:00:49 UTC 2021
PRIMARY
From To
1_22 1_96
1_146 1_202
1_222 3_219
1_228 2_228
1_231 2_231
1_263 1_323
1_369 1_427
2_22 2_96
2_146 2_202
2_222 4_219
2_263 2_323
2_369 2_427
3_23 3_93
3_139 3_199
4_23 4_93
4_139 4_199
Related Record Type Details
TARGET->LIGAND
TARGET -> INHIBITOR
Related Record Type Details
ACTIVE MOIETY
Name Property Type Amount Referenced Substance Defining Parameters References
Biological Half-life PHARMACOKINETIC
Molecular Formula CHEMICAL
MOL_WEIGHT:SEQUENCE CHEMICAL
Volume of Distribution PHARMACOKINETIC